Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...
Global healthcare infrastructure relies heavily on accurate biochemical diagnostics. The global creatinine test market ...
At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile ...
If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chr ...